Dr. Reichel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
260 Tremont Street
Bwd 10
Boston, MA 02116Phone+1 617-636-1648Fax+1 617-636-4866
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1989 - 1992
- Massachusetts General HospitalInternship, Internal Medicine, 1986 - 1987
- Albert Einstein College of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1992 - 2025
- FL State Medical License 2012 - 2018
- ME State Medical License Active through 2000
- RI State Medical License 1996 - 1999
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Eplerenone for Central Serous Chorioretinopathy Start of enrollment: 2013 May 01
- Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept Start of enrollment: 2019 Feb 22
Publications & Presentations
PubMed
- 347 citationsMutations within the Rhodopsin Gene in Patients with Autosomal Dominant Retinitis PigmentosaThaddeus P. Dryja, Terri L. McGee, Lauri B. Hahn, Glenn S. Cowley, Jane E. Olsson
The New England Journal of Medicine. 1990-11-08 - 777 citationsA point mutation of the rhodopsin gene in one form of retinitis pigmentosaThaddeus P. Dryja, Terri L. McGee, Elias Reichel, Lauri B. Hahn, Glenn S. Cowley
Nature. 1990-01-25 - 438 citationsTopography of Diabetic Macular Edema with Optical Coherence TomographyMichael R. Hee, Carmen A. Puliafito, Jay S. Duker, Elias Reichel, J. G. Coker
Ophthalmology. 1998-02-01
Press Mentions
- Market Cap of EyePoint Pharmaceuticals Inc. [EYPT] Reaches 65.23M – Now What?November 27th, 2020
- EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4November 19th, 2020
- Citation: Versek C, Banijamali SMA, Bex PJ, Lashkari J, Kamarthi SC, Sridhar S (2020) Portable Objective Diagnostics Using Visual Evoked Potentials for Age-Related Macular Degeneration. J Clin Exp Ophthalmol. 11:863November 2nd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: